ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 3618 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 3618; 2) Community: the network communities that were significantly associated with the response to NSC 3618; 3) Molecule: the relationships between components within communities and NSC 3618; 4) MDR: the compounds that were significantly associated with the NSC 3618.

NSC Compound Enrichment Correlation
NSC 740602 Null 0.0446159312763235 0.27776794
NSC 744025 diethyl 2-[4-(5-[(11aS)-7-methoxy-5-oxo-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-8-yl]oxypentyl)piperazino]ethylphosphonate 0.0446159312763235 0.24603208
NSC 94600 Camptothecin 0.0446159312763235 -0.1156587
NSC 625498 4-Morpholinecarbodithioic acid, antimony complex 0.0459335986102862 0.17563514
NSC 630375 2H-1-Benzopyran-2-one, 4-(2-benzofuranyl)-7-methoxy- 0.0459335986102862 -0.19154535
NSC 631305 cis-Dichlorobis(4-methoxyphenethylamine)platinum(II) 0.0459335986102862 0.39576766
NSC 632790 Platinum, dichloro(quinoline-N)[sulfinylbis(methane)-S]-, (SP-4-1) 0.0459335986102862 0.41093476
NSC 638294 Null 0.0459335986102862 0.22633442
NSC 651590 ANTINEOPLASTIC-651590 0.0459335986102862 0.2182093
NSC 664303 Acetic acid, 1,1,1-trifluoro-2-(trifluoromethyl)-3-(2-quinolinyl)-2-propyl ester 0.0459335986102862 0.42482035
Total:77  Current:68    [First] [Prev] [Next] [Last]